Leann Smith Sells 190 Shares of McKesson (NYSE:MCK) Stock

McKesson Corporation (NYSE:MCK) EVP Leann Smith sold 190 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the transaction, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. The trade was a 5.98% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

McKesson Stock Up 0.0%

MCK stock traded up $0.05 on Wednesday, reaching $946.52. 522,425 shares of the company’s stock were exchanged, compared to its average volume of 757,841. The stock has a fifty day moving average of $845.88 and a 200-day moving average of $792.02. The firm has a market cap of $115.94 billion, a PE ratio of 27.22, a P/E/G ratio of 1.50 and a beta of 0.40. McKesson Corporation has a twelve month low of $594.34 and a twelve month high of $971.93.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same period in the prior year, the company posted $8.03 EPS. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities research analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MCK. Morgan Stanley restated an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Evercore reaffirmed an “outperform” rating and issued a $1,000.00 target price on shares of McKesson in a research note on Thursday, November 6th. JPMorgan Chase & Co. upped their price objective on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Zacks Research cut McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 25th. Finally, Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and an average target price of $943.50.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. University of Texas Texas AM Investment Management Co. acquired a new position in McKesson during the fourth quarter valued at approximately $25,000. Swiss RE Ltd. acquired a new stake in McKesson in the 4th quarter valued at $26,000. GGM Financials LLC acquired a new position in shares of McKesson during the third quarter worth about $25,000. Solstein Capital LLC boosted its position in shares of McKesson by 171.4% in the second quarter. Solstein Capital LLC now owns 38 shares of the company’s stock worth $28,000 after buying an additional 24 shares during the period. Finally, State of Wyoming purchased a new stake in shares of McKesson in the second quarter worth about $29,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.